A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil, and low-dose cisplatin (MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG9501)

Gastric Cancer

Volumn 9, Issue 3, 2006, Pages 185-191

  Nakayama, Norisuke ^a   Koizumi, Wasaburo ^a   Tanabe, Satoshi ^a   Sasaki, Tohru ^a   Saigenji, Katsunori ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Combination chemotherapy; Histologically diffuse type gastric cancer

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; CISPLATIN; CREATININE; FLUOROURACIL; FOLINATE CALCIUM; METHOTREXATE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; ASCITES TUMOR; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE FREE SURVIVAL; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FOOD INTAKE; HISTOLOGY; HUMAN; LEUKOPENIA; LOW DRUG DOSE; MALE; NAUSEA; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; STOMACH CANCER; STOMATITIS; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PLEURAL EFFUSION, MALIGNANT; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33748885252     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-006-0371-x     Document Type: Article

References (39)

1. JR Bertino WL Sawicki CA Lindquist VS Gupta 1977 Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil Cancer Res 37 327 8
2. T Konishi M Hiraishi K Mafune T Miyama T Hirata K Mori 1994 Therapeutic efficacy and toxicity of sequential methotrexate and 5-fluorouracil in gastric cancer Anticancer Res 14 1277 9
3. KJ Scanlon EM Newman Y Lu DG Priest 1986 Biochemical basis for cisplatin and 5-fluorouracil synergism in human sovarian carcinoma cells Proc Natl Acad Sci USA 83 8923 5
4. T Shirasaka Y Shimamoto H Ohshimo H Saito M Fukushima 1993 Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo Cancer Chemother Pharmacol 32 167 72
5. R Dickinson P Presgrave J Levi S Milliken R Woods 1989 Sequential moderate-dose methotrexate and 5-fluorouracil in advanced gastric adenocarcinoma Cancer Chemother Pharmacol 24 67 8
6. G Blijham H Bleiberg N Duez M Buyse 1990 An EORTC phase II study of sequential methotrexate-fluorouracil in locally advanced or metastatic gastric cancer. The EORTC Gastrointestinal Cancer Cooperative Group Eur J Cancer 26 63 5
7. M Murakami K Ota T Miyazaki Y Niitsu A Wakui M Yokoyama 1987 Sequential methotrexate - 5-fluorouracil (MTX-5FU) treatment for patients with advanced gastric and colorectal cancer (in Japanese with English abstract) Jpn J Cancer Chemother 14 2482 90
8. T Sasaki K Ota J Ibayashi Y Sakata T Matsuoka M Ishikawqa 1989 Randomized muticenter trial: sequential methotrexate and 5-fluorouracil (MTX-5FU) versus 5-fluorouracil alone in advanced gastric and colorectal cancer (in Japanese with English abstract) Jpn J Cancer Chemother 16 2545 55
9. AJ Lacave FJ Baron LM Anton E Estrada LM De Sande I Palacio 1991 Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A phase II trial Ann Oncol 2 751 4
10. NK Kim YS Park DS Heo C Suh SY Kim KC Park 1993 A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer Cancer 71 3813 18
11. P Rougier M Ducreux M Mahjoubi JP Pignon S Bellefqih J Oliveira 1994 Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis Eur J Cancer 30 1263 9
12. A Ohtsu Y Shimada S Yoshida H Saito S Seki K Morise 1994 Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: report from the Japan Clinical Oncology Group (JCOG) Eur J Cancer 30 2091 3
13. Y Maehara H Anai H Kusumoto K Sugimachi 1987 Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well-differentiated carcinoma Eur J Surg Oncol 13 203 6
14. Japanese Research Society for Gastric Cancer 1995 Japanese classification of gastric carcinoma First English edition Kanehara Tokyo
15. World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: WHO offset/Publication No. 48; 1979
16. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 81
17. J Jolivet KH Cowan GA Curt NJ Clendeninn BA Chabner 1983 The pharmacology and clinical use of methotrexate N Engl J Med 309 1094 104
18. HW Bruckner JJ Lokich DM Stablein 1982 Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer. A Gastrointestinal Tumor Study Group Report Cancer Treat Rep 66 1713 17
19. DJ Fernandes JR Bertino 1980 5-Fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyridylate binding to thymidylate synthase by dihydropteroylpolyglutamates Proc Natl Acad Sci USA 77 5663 7
20. E Cadman R Heimer L Davis 1979 Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism Science 205 1135 7
21. E Cadman R Heimer C Benz 1981 The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells J Biol Chem 256 1695 704
22. SI Hironaka N Boku A Ohtsu F Nagashima Y Sano M Muto 2000 Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with bone metastasis Gastric Cancer 3 19 23
23. T Konishi T Miyama S Sakamoto T Hirata K Mafune M Hiraishi 1992 Activities of thymidylate synthetase and thymidine kinase in gastric cancer Surg Oncol 1 215 21
24. PG Johnston HJ Lenz CG Leichman KD Danenberg CJ Allegra PV Danenberg 1995 Thymidylate synthase gene and protein expression correlate and associated with response to 5-fluorouracil in human colorectal and gastric tumors Cancer Res 55 1407 12
25. PG Johnston ER Fisher HE Rockette B Fisher N Wolmark JC Drake 1994 The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer J Clin Oncol 12 2640 7
26. M Beer G Cocconi G Ceci M Varini F Cavalli 1983 A phase II study of cisplatin in advanced gastric cancer Eur J Cancer Clin Oncol 19 717 20
27. AJ Lacave I Izarzugaza LM Anton Aparicio M Valle Pereda JM Gracia Marco JM Buesa 1983 Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer Am J Clin Oncol 6 35 8
28. L Leichman B [tmp] McDonald A Dindogru M Samson VK Vaitkevicius 1984 Cisplatin. An active drug in the treatment of disseminated gastric cancer Cancer 53 18 22
29. SE Vogl FJ Camacho PF Engstrom JM Bennett 1984 Phase II trial of cisplatin in advanced gastric cancer Cancer Treat Rep 68 1497 8
30. K Aabo H Pedersen M Rorth 1985 Cisplatin in the treatment of advanced gastric carcinoma: a phase II study Cancer Treat Rep 69 449 50
31. AJ Lacave J Wils E Diaz-Rubio M Clavel A Planting H Bleiberg 1985 cis-Platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative Group Eur J Cancer Clin Oncol 21 1321 4
32. JD Hainsworth DH Johnson FA Greco 1992 Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience J Clin Oncol 10 912 22
33. B Drewinko BW Brown JA Gottlieb 1973 The effect of cis- diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications Cancer Res 33 3091 5
34. JF Belliveau MR Posner L Ferrari GW Crabtree FJ Cummings MC Wiemann 1986 Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion Cancer Treat Rep 70 1215 17
35. T Konishi T Hirata T Miyama M Hiraishi K Mafune J Yohida 1992 Mechanism of synergism and clinical results of sequential methotrexate and 5-fluorouracil in the treatment of gastric cancer (in Japanese with English abstract) Jpn J Cancer Chemother 19 946 53
36. T Yamao Y Shimada K Shirao A Ohtsu N Ikeda I Hyodo 2004 A phase II study of sequential methotrexate and 5-fluorouracil for advanced gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial Jpn J Clin Oncol 34 316 22
37. M Tahara A Ohtsu N Boku F Nagashima M Muto Y Sano 2001 Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with peritoneal dissemination: a retrospective study Gastric Cancer 4 212 8
38. T Konishi T Noie J Yoshida K Mafune M Makuuchi 1999 Treatment of peritoneal dissemination of gastric cancer with sequential methotrexate and 5-fluorouracil Gastric Cancer 2 52 6
39. A Thyss G Milano J Kubar M Namer M Schneider 1986 Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen Lancet I 256 8